CREST-2 Long-term Observational Extension Study
Launched by MAYO CLINIC · Jul 15, 2022
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Atherosclerotic plaque in the carotid arteries is responsible for 10 to 15% of all ischemic strokes. The ongoing NINDS-funded CREST-2 multicenter randomized clinical trial is testing whether in the short term (up to 4 years after study entry) procedural revascularization improves stroke prevention above and beyond what can be achieved with intensive medical management of vascular risk factors, especially hypertension and hyperlipidemia. Our proposal is for an observational extension of the CREST-2 clinical trial to test whether revascularization improves stroke prevention in the clinically ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently active or graduated participants in the CREST-2 randomized trial
- • Able to provide written informed consent by self
- • Fluent in English or Spanish
- Exclusion Criteria:
- • Unable to provide written informed consent
- • Inability to follow study procedures
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Rochester, Minnesota, United States
Portland, Maine, United States
Jacksonville, Florida, United States
Detroit, Michigan, United States
Birmingham, Alabama, United States
Jacksonville, Florida, United States
Hartford, Connecticut, United States
Falls Church, Virginia, United States
Boston, Massachusetts, United States
Providence, Rhode Island, United States
Chicago, Illinois, United States
Stockton, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
New York, New York, United States
Iowa City, Iowa, United States
Miami, Florida, United States
New Haven, Connecticut, United States
San Francisco, California, United States
Barcelona, , Spain
Seattle, Washington, United States
La Crosse, Wisconsin, United States
Winston Salem, North Carolina, United States
Lansing, Michigan, United States
Baltimore, Maryland, United States
New Orleans, Louisiana, United States
Saint Louis, Missouri, United States
Wyomissing, Pennsylvania, United States
Lexington, Kentucky, United States
Harrisburg, Pennsylvania, United States
Tucson, Arizona, United States
Fremont, California, United States
Salt Lake City, Utah, United States
Gainesville, Florida, United States
Springfield, Illinois, United States
Jacksonville, Florida, United States
Pittsburgh, Pennsylvania, United States
Knoxville, Tennessee, United States
Toledo, Ohio, United States
Silver Spring, Maryland, United States
Flint, Michigan, United States
Phoenix, Arizona, United States
Little Rock, Arkansas, United States
Los Angeles, California, United States
San Francisco, California, United States
New Haven, Connecticut, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
Panama City, Florida, United States
Golden Valley, Minnesota, United States
Ann Arbor, Michigan, United States
Newburgh, Indiana, United States
Patients applied
Trial Officials
James Meschia, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials